Custom regulatory and clinical strategy workshops

A strong regulatory and clinical strategy early on can save months of rework later.

Why Data and AI Skills Are Becoming Critical in Life Science Teams

Life Science organizations are investing heavily in data platforms, digital tools and AI driven solutions. From production and quality to clinical development a...

Drug approved for condition causing extreme hunger

The U.S. Food and Drug Administration (FDA) has for the first time approved a drug for acquired hypothalamic obesity, a condition marked by rapid weight gain dr...

Disappointment for Diamyd in Phase III – the share price plunges

Diamyd Medical’s share was sharply down on Monday following negative Phase III results. “This outcome is highly unexpected,” said the company’s CEO, Ulf Hannelius.

How MoniDose strengthened their regulatory confidence—fast

When MoniDose began their startup journey, regulations were their biggest challenge. Missing early design inputs tied to standards could have meant costly redesigns later.

Sprint Bioscience builds the molecules that will become new medicines

In Sprint Bioscience’s laboratory in Flemingsberg, Huddinge, molecules are being created that no one has ever built before. The company specializes in preclinic...

Nordic collaboration delivering the next leap in spatial biology

Spatial biology is reshaping how researchers understand complex tissue environments, from tumour–immune interactions to treatment response. A major barrier has ...

Atrogi on its challenger to GLP-1: “Now we are stepping forward”

A new approach to treating type 2 diabetes and obesity is taking shape in a laboratory just a stone’s throw from the Karolinska Institute. At Atrogi, researcher...

Important notification for IVDR Class C device manufacturers

Deadline for application is quickly approaching; 26 May 2026.

Paul Chaplin steps down as CEO of Bavarian Nordic

Danish vaccine company Bavarian Nordic’s CEO, Paul Chaplin, is stepping down from his position for personal reasons.

End of bone‑sawing? New laser cuts to record depths

Saw, drill and chisel are a bone surgeon’s best friends today – but soon the laser may also find its place in that toolbox. Researchers in Switzerland have disc...

A cluster contribution to European life science innovation and competitiveness?

Any Image Size, Many Formats, AI-Powered

ZEISS arivis optimizes local server or cloud computation resources.

Automated high-speed scanning of probes

ZEISS Axioscan 7 spatial biology.

Networking event in Denmark: Sponsor Oversight in Clinical Trials

We are excited to invite clinical trial professionals to a networking event to connect and discuss best practices, challenges and adaptive strategies in documen...

New antibody aims to slow kidney damage – “It’s kind of cool”

For 25 years, Marie Jeansson has studied the kidney and its blood vessels. She is now working on developing a drug intended to slow down chronic kidney disease.

Lost in the recruitment process? How hiring really works today

As recruitment becomes increasingly automated, candidates are expected to adapt to both human and algorithmic decision-making. Career coach Tina Persson outline...

Mercodia AB

More than 150 jobs cut as Merck scales back vaccin production

Merck & Co, known as MSD in Europe, is hitting the brakes following a sharp decline in demand for its HPV vaccine Gardasil. Production at its facility in Durham...

Novo Nordisk strengthens board after turbulent year

Changes to Novo Nordisk’s board continue. Following last year’s sweeping restructuring, the Danish obesity drugmaker is now nominating two new directors with ex...

Meet Aurevia at the next Medicon Village Science for Breakfast

Join us for Science for Breakfast at Medicon Village on May 19th!

Supporting Investigator Initiated Clinical Studies—From Start to Finish

Many important clinical studies start with researchers – not pharmaceutical companies. In investigator initiated studies, pharmaceutical companies often support...

Anna Törner: ”Drug prices – an important driver of innovation”

We live under the illusion that no price is too high when it comes to health, but that simply isn’t true, writes Anna Törner.

We are expanding our English-language coverage

Over a period of four weeks, one of Life Science Sweden's regular daily newsletters is being published entirely in English. The aim is to meet increasing demand...